A model has been proposed to estimate R-loop levels and their prognostic value in cancer RNA-sequencing datasets (Zhang et al., 2024), and PARP1 activation at R-loops has been suggested as a potential predictive biomarker for sensitivity to PARP and ATR inhibition (Liu et al., 2024). Here, PARP1 is linked to cancer.